Why the study?
Does lercanidipine reduce blood pressure in patients with arterial hypertension?
Does lercanidipine reduce blood pressure in patients with arterial hypertension?
Lercanidipine is an effective, safe, and well-tolerated third-generation calcium antagonist for the treatment of hypertension.
Supports lercanidipine for hypertension with neutral HR effects; leaves open prospective randomized confirmation.
The data from clinical trials that have examined the efficacy and safety of modern third generation calcium antagonist-lercanidipine is presented herein. Results of the following studies demonstrate that treatment with lercanidipine leads to a marked reduction in systolic and diastolic blood pressure without a significant impact on heart rate. Unique pharmacokinetic characteristics of the drug provide its high efficacy and safety, tolerability, convenience, acceptance and high adherence of the said CA in AH patients. Additional lercanidipine properties allow us to recommend the use of this CA in associated pathology cases.
No takes yet. Share an insight, caveat, or question.
Vs et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: